Hunter Cancer Research Alliance (HCRA)

As a multidisciplinary and multi-institutional alliance, the Hunter Cancer Research Alliance (HCRA) functions to provide capacity building, funding and strategic support to cancer research across the translational research continuum – from basic research through clinical trials to behavioural, implementation and health services research.

With the support of our partnering institutions, executive leaders and a membership that consists of 450+ cancer-focused researchers, we are working to promote the excellence of cancer research in the Hunter and ultimately improve cancer patient outcomes in our region and beyond.

Our objective

HCRA is using evidence-based science to advance precision healthcare whereby 'the right person gets the right care at the right time'. Precision healthcare involves profiling (molecular, physical, psychosocial, behavioural and system-focused) of each patient and tumour, coupled with the development and implementation of specific treatments (including prevention) that are tailored to each person’s or each community’s requirement.

The aim of HCRA is to develop a sustainable translational cancer research enterprise and apply it to identified areas of need in a logical, scientific and focused manner.

Our goals

  1. Accelerate the adoption of research generated evidence into practice for improved patient outcomes
  2. Drive the efficiency and effectiveness of incorporating research, clinical training, education and service delivery
  3. Collaborations within the centre’s clinical and research disciplines
  4. Collaborations between other centres of research and clinical excellence
The University of Newcastle, Australia Hunter New England Local Health District Calvary Mater Newcastle Hunter Medical Research Institute Cancer Institute NSW